AB Science, a young Paris-based biotech company, has announced the pan-European commercial launch of its veterinary anticancer drug, Masivet
Masivet was approved in November 2008 by the European Medicines Agency (EMEA) for the treatment of dogs with non-resectable grade 2 or 3 mast cell tumours. Masivet's active pharmaceutical ingredient is masitinib, a tyrosine kinase inhibitor. Masitinib, discovered and developed by AB Science, belongs to a therapeutic class of drug known as targeted therapy that is, according to AB Science, revolutionising the treatment of cancer in humans.
Alain Moussy, CEO of AB Science said: "Masivet is the first product ever registered as a cancer treatment in veterinary medicine. AB Science is a dynamic and very entrepreneurial biotech company, and is proud to have introduced a drug that can extend the life of dogs suffering from cancer ahead of the large pharmaceutical companies".
The company says Mastocytoma can be an aggressive cancer with a poor prognosis, and represents up to 20% of all cutaneous canine tumours. Some breeds are particularly susceptible, among them Golden Retrievers, Labradors and Boxers. Cancers have the same prevalence in dogs as in humans (1 dog in 4 will suffer from cancer during its lifetime) but surprisingly, no drugs developed for veterinary medicine with a demonstrated efficacy and safety have ever been approved until the arrival of Masivet.
The company claims two main benefits of the new treatment:
AB Science is a biotech company specialising in developing targeted drugs for high need indications, such as cancers, chronic inflammatory diseases and neurodegenerative disorders. Masitinib is the most advanced drug in the pipeline. Now being marketed in veterinary medicine, masitinib is also under development in humans, with phase 3 clinical studies in pancreatic cancer and in gastrointestinal stromal tumour (GIST).
Alain Moussy said: "This registration in veterinary medicine is good news for the future success of masitinib in humans, for whom we are aggressively developing it in cancers and other indications with high morbidity or pain.
"It is very unusual to develop such an innovative product simultaneously in veterinary and human medicines, and even more so that the product is registered in veterinary medicine first. There is no doubt that experts in human oncology will be watching Masivet's future very closely from now on.. However, people will have to wait a while before benefiting from masitinib because it is unlikely to be available to man before 2012".
For more information, see www.masivet.com and www.ab-science.com
Duoflect contains a new formulation of fipronil and (s)-methoprene which, according to the company, offers a 100% longer duration of action against fleas in cats (eight weeks), and a 13% longer duration in dogs (nine weeks) than the market-leading fipronil combination.
Ceva says the Duoflect's duration of action against ticks is 150% longer in cats (5 weeks) and 50% longer it cats (six weeks) than the market-leading competitor.
Duoflect acts against both adult fleas on the animal and immature flea stages in the environment and it can also be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
Duoflect is available in free-standing pipettes for easier administration and handling of the pet. The pipettes are packed in child-resistant aluminium blisters to reduce the risk of accidents at home.
Nicki Glen, marketing project manager for Duoflect at Ceva Animal Health said: "Recent research1 has revealed that two main factors in prescribing parasitic control products are the length of action and the increased efficacy against fleas.
"Duoflect's new strength formulation provides a longer duration of action than the market-leading fipronil combination, while its efficacy is proven through 13 recent laboratory and field trials1."
Duoflect is competitively priced and is available in boxes of three or six pipettes and in five presentations: small cats (1-5kg), large cats (>5kg) and small dogs (2-10kg) and medium dogs (10-20kg), large dogs (20-40kg) and extra large dogs (40-60kg). It is suitable for cats and dogs from eight weeks of age.
Ceva Animal Health has produced a range of supporting marketing materials including client leaflets.
For more information, contact your local Ceva Animal Health territory manager or call Ceva’s head office on 01494 781510.
Reference
The study, which is being carried out in partnership with the University of Bristol, will analyse flea samples submitted by vet practices from across the country.
Practices interested in participating can request flea collection packs by contacting their MSD representative, or by sending an email to infobfp@merck.com.
Participating practices will receive support materials, including flea combs and things to display in waiting rooms.
The campaign follows the success of the Big Tick Project launched in 2015, which examined over 6,000 tick samples in the UK contributing to the largest-ever study of ticks on dogs and cats in Britain.
Daniel Guerrero, Product Manager at MSD Animal Health said: "After receiving such groundbreaking results from the Big Tick Project, we wanted to continue to revolutionise the way that common parasites such as ticks and fleas are understood and treated by both pet owners and vets.
"Fleas are the most important parasite for pet owners and the main source of irritation in pets. Despite this, fleas are still seen as a common nuisance, and not often dealt with effectively. By better understanding what diseases fleas are carrying in the UK, we will be able to better explain the impact of fleas and how to eradicate them through professional advice and treatment from their local vet."
The Big Flea Project will be open to flea pack submissions from 1st of April – 1st of June 2018, with findings of the research published in 2019.
To request your flea collection pack and practice materials, contact infobfp@merck.com
'Hany’s Heartbreak' was a gorily realistic representation of a dog’s heart infected with Dirofilaria Immitis, baked by vet students Anna Burrows, Caitlin Glover, Chloe Tredinnick and Liberty Daly.
It pulled in votes from all over the world including Australia and the US, Saudi Arabia, Germany, Italy and the Caribbean.
The winning bakers said: "We chose to bake this cake as we wanted to make something that we could make look as realistic as possible and as gruesome.
"Our parasitology lecturer, Hany, inspired us to use the D. Immitis parasite as our theme to promote the message of how detrimental and possibly fatal some animal parasites can be! We had a great time baking it and enjoyed the looks of disgust that people who saw it gave. We promise it tastes better than it looks! Our key message to everyone is to PLEASE WORM YOUR PETS!"
The categories for baking inspiration this year were Transport to Campus, Scrumptious Science, Blue Planet and a Showstopper section. Sir David Attenborough and Pixar characters Nemo and Dory were among the other stars of the show, with colourful cakes on an environmental theme also winning prizes.
One of this year’s judges was Dr Wendela Wapenaar, Associate Professor at the Nottingham Vet School. Wendela said: “It’s been another great year for the Sutton Bonington Bakeoff. It was impressive to see how some bakers took on the challenging topics for this year; winning cakes were covering topics such as global warming, environmental pollution in addition to the more gory aspects of veterinary medicine."
Bacteria isolated from human dental units analysed in other studies included Pseudomonas Sp, Mycobacteria and Legionella.
Bob said: "The Care Quality Commission (CQC) would have no hesitation in shutting down practices with the level of contamination we have seen. The dangers are real and significant for our teams as well as for our patients.
"Part of the problem is that dental units produce aerosols which can carry the bacteria into the depths of the lungs, bypassing normal defence mechanisms. Endotoxin levels have also been shown to be very high in untreated units, potentially resulting in problems when surgical extractions are performed.
Bob added: "The good news is that the biofilms which harbour the bacteria are treatable - but simply adding a little chlorhexidine will not do the trick."
Working with industry leaders, www.VetDentist.info has produced a Starter Kit for veterinary practices, which Bob says will clear biofilms and also provides a safe maintenance solution for ongoing use.
Bob says the cost of keeping your dental unit’s water lines safe for staff and patients is around 25-40p per day. Practices can also sign up for a regular monitoring scheme.
For more information and to get a VetDentist Starter Kit, visit www.VetDentist.info.
As part of its new strategy the RSPCA has also announced it is exploring the transfer of its animal welfare prosecuting role to the CPS to focus on its frontline work rescuing and caring for animals and investigating cruelty.
The ambitions announced by the charity are:
RSPCA Chief Vet Caroline Allen said: "Our grassroots and frontline work will still be at the heart of what we do - as it has been since the RSPCA’s inception almost 200 years ago.
"The RSPCA recognises that we simply cannot perform our vital frontline work without the support and expertise of vets and vet nurses across the country. As part of this strategy we are aiming to strengthen these relationships and improve understanding and communication between the RSPCA and the veterinary professions.
"Vets and RVNs - both in private practice and within the RSPCA - play many critical roles; including providing veterinary care to abused animals rescued by the RSPCA, supporting our animal centres and our prosecution work, as well as reporting abused and neglected animals to us.
"We know that vets and RVNs want to have a better understanding of what they can expect from us and we will provide more clarity around what we are asking of vets when they treat our animals. We will continue to draw on and support the strong and growing evidence base in the profession in areas such as shelter medicine, veterinary forensics, clinical behaviour and accessible care.
"We know that the veterinary sector has had a tough year and we are very grateful for your continuing support of our work during the many challenges of the pandemic."
Commenting on the decision to look at transferring its animal welfare prosecuting role to the CPS, RSPCA chief executive Chris Sherwood said: “We are proud of our history bringing animal abusers to justice and for many years we have been the right people to do this vital work. However, the world has changed and we have to change with it.
"We launched our new strategy this week and a key part of this is working in partnership with other organisations with the responsibility and expertise to support our work.
"The CPS is the statutory body with responsibility for taking prosecutions in England and Wales and by working more closely in partnership with them, we can free up resources to focus on our unique frontline investigation, rescue and care work, where we can make the most difference to animals.
"However, we reserve the right to take a prosecution in future if we feel that justice is not being done for animals."
The charity is also seeking statutory powers under the Animal Welfare Act 2006 for its frontline animal rescuers.
This means that they would be able to reach animals faster, allowing them to access private land and outbuildings, although crucially not homes, if there was a reasonable expectation that an animal was suffering.
These changes would bring England and Wales in line with Scotland and Ireland where the SPCAs have statutory powers and pass their cases to the state prosecutor.
To find out more and download the RSPCA’s new strategy, visit: https://www.rspca.org.uk/whatwedo/strategy
It is estimated that there are more than one million pet ferrets in the UK and a further 500,000 in the United States, but until now little was known about how ferrets are housed and what environmental enrichment they benefit from.
For the study1, RVC researchers analysed 750 responses to an online questionnaire from ferret keepers (82% of whom were pet owners and the remainder were from the laboratory, zoo, rescue and pest control sectors) from 17 countries.
The study found that most ferrets were housed with at least one other ferret, providing social interaction.
The environmental enrichments that ferret keepers believed their ferrets most enjoyed were tunnels (42.5%), digging (27.3%), human interaction (20.8%) and exploration (17.6%).
The items reported as being most problematic included rubber toys, which can cause internal blockages when chewed and swallowed (45.1%) and enrichments which can result in claws or other body parts becoming trapped, such as narrow tunnels and certain fabrics including fleece, towels and loosely woven fabrics (28.6%).
Other main findings included:
Alice Dancer, PhD Student at the RVC, and lead author of the paper, said: “How animals are housed and the environmental enrichment they are given can have a significant impact on their health and wellbeing.
"The finding that large housing and high numbers of enrichment are possible in all ferret-keeping sectors is a really good sign for ferret welfare.
"We hope that these results help inspire ferret caretakers to consider the housing they use, offer ideas for new ferret enrichments, and raise awareness of enrichments which may harm their ferrets.”
Research shows that over 60% of cast-treated pets get additional injures, such as pressure sores, from traditional plaster casts1.
The new cast is designed to tackle these issues with anatomically shaped bi-valve splints that are based on 30,000 3D scans of animal limbs.
Upets TLC products are made from FDA and CE approved Woodcast material used in human casting and splinting.
Bandages, padding and tape are replaced with a soft, self-cohesive Unitex fabric that passes moisture and dries fast.
TLC products are engineered for easy destabilisation by removing parts of the splint, and the same product can be used throughout the whole treatment.
Orthopets, a subsidiary of the materials company Dassiet, says that breathable, lightweight materials combined with the anatomical fit help prevent sores and restore normal position and movement of the limb.
OrthoPets founder Martin Kaufmann said: “The common cast is very problematic, but we've lacked better alternatives. Now, with the Dassiet supermaterials and OrthoPets’ vast experience in veterinary biomechanics we have re-engineered the common cast.
"Upets TLC is anatomical and safe. It’s stress-free for both the vet and the pet. It brings veterinary casting to the modern day and offers a better standard care option for all vets and orthopaedic surgeons out there.”
"Sores, pain and stiffness are always on the horizon with casting. But if we take the cast off too early, the leg can be injured again because of lack of proper support. UPETS tackles these problems all at once. I find it easy to apply the pre-shaped casts even for very small or large dogs and make adjustments if needed. I can watch my patients walk off the clinic normally with their cast, knowing they can wear it safely until fully healed. We see significant and immediate improvement in patients compared to the common cast”, says Dassiet Chief Veterinarian Jouni Niemi, who oversees the clinical research of UPETS.
For more information, visit: www.upets.vet/TLC
Written by members of BSAVA Scientific Committee, together with specialists in internal medicine and neurology, the document explains that there are limited studies showing beneficial effects of CBD, and those that there are need to be interpreted with caution as they involved small sample sizes and used unlicensed products which may have contained other components which could have influenced the results.
The document also explains that legally, CBD products must be prescribed by a veterinary surgeons and not used instead of a medication with proven efficacy.
Caroline Kisielewicz, BSAVA Scientific Committee member and one of the authors of the document said: “Information regarding the effects of cannabinoids on animals is predominantly at the stage of pre-clinical testing of individual substances in mice, rats and guinea pigs. There are limited clinical studies looking at the effects of CBD in dogs, and no reported studies in cats.
"There are many reports describing possible beneficial effects and therapeutic potential in humans, and subsequently pet owners may ask their vet about using cannabinoids to treat veterinary patients. This document aims to provide a broad overview of the available evidence base and legal position in the UK for veterinary team members."
BSAVA President, Ian Ramsey added: "The development of this information is in direct response to an increased interest in the use of CBD to treat cats and dogs. Furthermore, the guidance supports BSAVA’s mission to promote excellence in small animal practice through community, education and science."
The BSAVA position on CBD can be accessed here: https://www.bsavalibrary.com/content/chapter/10.22233/9781910443514.chap8#html_fulltext.
Tranquinervin, which contains 10 mg/ml acepromazine, is indicated for anaesthetic premedication, tranquilisation and sedation.
Emma Jennings, Brand Manager at Dechra said: "Tranquinervin provides tranquillisation or a mild sedation for several hours, making it a valuable tool for many day-to-day veterinary scenarios.
"At low doses, acepromazine reduces anxiety which is beneficial for use in horses prior to shoeing or transportation. At higher dose rates, it is an effective sedative for use in situations like dentistry or handling. The relaxant effects also aid examination of the penis in horses and the treatment of tetanus and choke.
"There is also reduced anaesthetic risk reported following sole premedication with acepromazine in healthy horses1."
Tranquinervin is available in a 20 ml vial with a 56 day broached shelf life. It can be used in conjunction with Dechra’s equine anaesthesia and analgesia app which is designed to help you choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates quickly and easily.
For more information, go to: www.dechra.co.uk/products/equine
The journal publishes original peer-reviewed papers of international or global significance that improve the veterinary care and welfare of domestic cats.
Until this year, access to JFMS for most veterinary practitioners was dependent on membership to the International Society of Feline Medicine (ISFM) or the American Association of Feline Practitioners (AAFP), or a separate paid subscription.
Now that the journal is open access, there are no restrictions on who can access the journal and all articles past and present are free to view.
The journal's editors say that making it open access greatly improves their ability to improve the health and welfare of cats by providing high-quality peer-reviewed information.
The AAFP and ISFM say they have already seen the positive impact this has had, with low- and middle-income countries now accounting for a quarter of the 20 most common geographic locations for visitors to the JFMS website.
Head of ISFM Nathalie Dowgray said: "Transitioning JFMS to an open access journal helps ISFM fulfil our parent charity’s (International Cat Care) mission of creating a cat friendly world through ensuring the latest knowledge in feline medicine and welfare is available to the global veterinary community."
For those interested in submitting to JFMS, authors can get a 50% discount on the article processing charge until 4 July 2023; after this date, a 22% discount will be in place for authors who are a member of ISFM or the AAFP.
Click here for more information about submitting an article to JFMS: https://journals.sagepub.com/author-instructions/JFM
https://journals.sagepub.com/home/jfm
Comments received from students included: "They are an extremely supportive team that are very keen to teach and get the students involved at every opportunity" and: "They are very good at getting students involved and making them feel like part of the team".
Other winners included Fiona Ridout, pictured right, who won the award for the most engaged veterinary student on EMS placement. She had consistently excellent feedback across all her placements and significantly exceeded the RCVS required number of weeks for pre-clinical and clinical EMS. Feedback comments included: "Fiona has been highly motivated and reliable, always keen to help and gain experience"; "Fiona is one of the best students that we've have ever had"; 'Her clinical knowledge improves each time she visits", and: "Interactions from staff and clients have been impressive".
Golden Valley Vets in Nailsea Park, Bristol won the students’ award for most supportive veterinary nursing placement practice. Comments received from students included: "All the staff were really friendly, welcoming and patient and I left feeling like part of the team", and: "I was actively encouraged and supported with my Nursing Progress Log during my time there".
Megan Piper won the award for the most engaged veterinary nursing student on EMS placement. Megan received excellent feedback from her EMS placements and from her rotations. Feedback comments included: "When Megan qualifies she will make an excellent nurse and a very valued member of any team"; "Megan has consistently demonstrated a professional, motivated approach to her work in practice", and: "Our Referral Vets and Clinical Director were all very sad that she has finished her placement with us, and have invited her to come back once she has qualified".
Veronica Roberts, Senior Clinical Fellow in Equine Medicine at the University of Bristol said: "The University of Bristol believes that EMS prizes encourage and acknowledge student learning in a practical ‘real world’ situation, thus supporting the university in its aim to prepare graduates for day one competencies and life-long learning. We are grateful to practices for the invaluable contribution they make towards student education through offering EMS placements."
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "At Zoetis we are dedicated to supporting animal health through a wide range of quality medicines, vaccines, services and education so we are proud to sponsor these important prizes. They enable winning students to choose a preferred academic resource to help support them during their important first years in practice, while the winning practices can be formally thanked for their invaluable commitment and support."
Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging1) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCTs in dogs. Tumours must be less than or equal to 8cm3 in volume and must be accessible to intratumoural injection.
The company says that a single intratumoural treatment has been seen to destroy the tumour completely in 75% of observed cases.
The active ingredient in Stelfonta is tigilanol tiglate, a compound extracted from Fontainea picrosperma, a shrub found in the Australian rain forest. According to the company, it works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
Virbac says that generally, dogs do not require sedation or local or general anaesthesia during treatment.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Stelfonta is an innovative yet simple treatment which provides a high tumour elimination rate, rapid healing and a speedy return to a good quality of life for the pet. In the cases studied, the tumour was destroyed in seven days and full wound healing observed in 96.5% of cases, with no significant adverse effects on the dog.
“The effects of Stelfonta really do need to be seen to be believed."
The new app, which is being being made available in the run up to Pet Diabetes Month in November, allows owners to track water and food consumption, exercise, glucose levels and insulin injections on their smartphone or tablet. It can also send reminders for veterinary appointments and insulin injections, and creates charts that clients can share with their veterinary surgeon.
MSD says the Pet Diabetes Tracker will help improve client reporting and compliance, resulting in improved pet welfare and a reduction in risk to pets through its alert system.
Caroline Darouj, Product Manager at MSD Animal Health said: "To help ensure the long-term health and well-being of a pet, successfully managing the various facets of the disease and treatments is critical.
"With proper management and monitoring a dog or cat with diabetes can lead a healthy, happy and active life, and the Pet Diabetes Tracker can help make it happen. This is an incredibly useful tool that links the pet owner with the vet and puts all the pertinent diabetic health information at their fingertips. It’s all about setting habits that save lives!"
The Pet Diabetes Tracker can be downloaded from iTunes, here: https://itunes.apple.com/uk/app/pet-diabetes-tracker-uk/id1284472796?ls=1&mt=8.
MSD says an Android version will also be available soon.
For more information, visit www.petdiabetesmonth.co.uk or contact your MSD Animal Health account manager.
The RCVS Disciplinary Committee has this week directed that the name of a Grimsby veterinary surgeon should be removed from the RCVS Register, having found him guilty of serious professional misconduct for advising and undertaking surgical procedures without sufficient clinical grounds or considering alternative treatment options; failing to obtain the informed consent of his clients; undertaking procedures outside his area of competence; failing to refer or discuss the option of referral to a specialist; and, failing to provide his patients with adequate pain relief.
Mr Joseph Lennox Holmes, of Waltham Veterinary Clinic, Grimsby, faced nine charges relating to two separate complaints, at a two-week hearing in October which resumed this week.
These complaints concerned four consecutive staphylectomies and a tracheostomy that Mr Holmes performed on Jake, a Cavalier King Charles Spaniel owned by Ms Marsden; the dental treatment he gave to three Persian cats called Dream Topping, Charlie Brown and Henry, together with the advice he gave to their owner, Mrs Auckland.
On 25 October 2007, Mr Holmes performed a staphylectomy on Jake during dental surgery. He gave the Committee various reasons why he thought the procedure was necessary; however, the Committee accepted the opinion of two expert witnesses Professor Dan Brockman, a specialist in soft tissue surgery at the Royal Veterinary College, and Mr Andrew Ash, the senior veterinary surgeon at a 17-vet small animal practice, that there were insufficient clinical grounds for such a surgical procedure to be undertaken. The Committee also found Mr Holmes had not adequately considered other treatments, or obtained fully informed consent from Jake's owner for this procedure.
Mr Holmes performed further staphylectomies and a tracheostomy on Jake, a procedure described by Professor Brockman as "by definition, high risk and best performed by a specialist". He did not consider referral, or inform Mrs Marsden that such referral was an option. Nor did he provide sufficient aftercare or pain relief. Following these surgeries, Jake was euthanased .
In the second complaint, Mr Holmes performed dental extractions on two cats, Dream Topping and Henry, and advised removing teeth from a third, Charlie Brown, in October 2008. The Committee, however, accepted the view of expert witness Mr Ash and Dr David Crossley, RCVS Recognised Specialist in Veterinary Dentistry, that the dental extractions performed, and the advice given, were not justified on the available clinical evidence. The Committee also found that Mr Holmes did not discuss alternative treatment options with Mrs Auckland, or obtain her informed consent. In the case of Dream Topping, consent was sought after the cat had been sedated for an unrelated procedure and Mrs Auckland had felt under pressure to consent.
Mr Holmes had also relied on anaesthesia-inducing drugs to provide analgesia for the dental extractions, without any other form of pain relief. The Committee agreed with the expert witnesses that this was wholly inadequate.
The Committee found many aggravating factors in both cases, including actual injury to animals from unnecessary surgery, and a serious breach of the trust in which Mr Holmes' clients had placed in him to make the welfare of their animals his primary consideration. His repeated misconduct had been sustained over a period of time in the face of a previous adverse finding of the Committee in 2006.
It also found that Mr Holmes failed to appreciate when a case was outwith his experience, and had continued his course of action despite Jake's deterioration; he had not considered referral or accepted that others in the profession might know more than he did; in formulating clinical practice and policies, he made no reference to peer-reviewed literature or continued professional development; and, his use of outmoded drugs and medicines intended for human use was of concern, as was his lack of appreciation of the need for adequate pain relief when performing painful surgical procedures.
Towards the end of the hearing, Mr Holmes said in mitigation that he regretted unreservedly any adverse effects that his treatment had had on the animals concerned, and that he now realised that his long history of working alone had allowed him to become professionally isolated, to become over-confident in the value of his own experience and rather "set in his ways".
Having given serious consideration to postponing judgment, subject to undertakings from Mr Holmes, Disciplinary Committee Chairman Mrs Caroline Freedman said: "We are mindful that the sanction which we apply must be proportionate to the nature and extent of the misconduct found proved and must balance the public interests against the interests of the Respondent.
"We are, however, also mindful of Mr Holmes' conduct during the previous 11½ days of the hearing, during which time his every action was vigorously defended and no insight whatsoever was shown."
The Committee also considered suspending Mr Holmes from the Register. "In view of the serious and long-term nature of the conduct found proved in the charges, we do not feel that it is appropriate that Mr Holmes should be permitted to return to the Register without further assessment of his efforts to update his knowledge," said Mrs Freedman, before concluding: "The only appropriate sanction in each case is that the Registrar be directed to remove Mr Holmes' name from the Register."
After tense negotiations which stretched well into the night, Jenny Smith MRCVS has been confirmed this morning as the new face of VetSurgeon.org.
Jenny, who qualified earlier this year (congratulations), will appear in advertisements for the site in Veterinary Practice magazine, The London Vet Show Guide and Cattle Practice. She said: "I'm only too pleased to help promote VetSurgeon.org. It helped me understand what happens in the real world whilst I was at university, and I got my very first job as a veterinary surgeon through the contacts I made on the site."
Jenny is the third face of VetSurgeon, replacing Niall Taylor MRCVS, who has held the post since taking over from Gillian Mostyn MRCVS in December 2009. He said: "I'm ruined. Ruined, you hear. Without this contract, I'll probably have to go and open branches of Aldi on wet Saturday afternoons."
In fine tradition, Jenny is donating her £100 fee to the Northern Rose Boxer Rescue charity.
According to head veterinary surgeon Simon Maddock, about one third of the practice's workload is now for guinea pigs – a figure growing year by year. More to the point, many of their clients are travelling a considerable distance to get veterinary care.
Simon said: "We certainly didn’t start out to become so popular with guinea pig owners; it’s happened more by word of mouth. Our reputation has grown mainly through owners talking to each other on online forums.
"I reckon we must see at least one guinea pig a day that has travelled more than 50 miles to see us. One couple regularly make a 175-mile round trip from North Wales. We even have someone visit us from Scotland. That’s one long trip to make!"
Simon added: “Although the practice was originally established to provide dedicated cat and rabbit owners with veterinary care specifically tailored to these pets, we have also found guinea pig owners to be just as committed to their pets and they are quick to look for signs of illness."
A survey carried out in 2008 by the British Veterinary Association and its student branch, the Association of Veterinary Students (AVS) has found that that one in three students find themselves in difficult or severe financial situations, more than half have suffered from stress, over a fifth from depression, over a quarter from anxiety and one in every 14 from an eating disorder.
The survey also found that some veterinary schools have almost doubled their intake of overseas veterinary students since the survey was last conducted in 2005.
Other key findings from the survey included:
The AVS suggests that there are opportunities for veterinary schools and the veterinary profession to improve the bleak financial picture for students. BVA already provides support meetings for young professionals and has put together a position statement which will kick-start a lobbying process for:
BVA President Nicky Paull said: "The BVA/AVS survey, a part of the BVA's continuing work on behalf of veterinary students, once again continues to highlight the growing problem of debt. This is a particular problem for veterinary undergraduates whose five year course by definition will attract more debt than the average three year undergraduate course.
"The impact of this increasing debt is twofold. Firstly, new graduates are more likely to choose their first jobs on the basis of salary and reducing debt rather than individual professional development. Secondly, we are concerned that as school leavers make career decisions on financial grounds, only those from relatively affluent backgrounds will choose the veterinary profession. This is contrary to the aims of Government to promote the DfES/Gateway to the Professions initiative. It would be sad to see such a vitally important undergraduate course become one which can only be undertaken by talented young people from families who feel they can afford to help with the long term costs.
"The veterinary undergraduate course is not only training future veterinarians on animal health and welfare but also in the essential role vets play in food safety and the health of the nation."
The full survey results can be downloaded here.
In case you missed the email last month, Novartis Animal Health has announced the launch of Atopica for Cats (cyclosporine oral solution, 100 mg/ml), a treatment for chronic allergic dermatitis.
This disease, which is apparently one of the most common reasons for pet owners to take cats to the veterinary surgeon2, can be difficult to diagnose and causes itching and associated chewing and licking, skin lesions and loss of hair. Atopica for Cats is the first medication approved in the UK specifically for allergic dermatitis in cats.
Novartis says the new product provides relief from the uncomfortable and recurrent itch/scratch cycle, and the majority of improvements are seen in the first four weeks3-5. The company also says that in clinical trials, 84 per cent of cats diagnosed with allergic dermatitis were considered to be "uncomfortable" at the start of the study5. After six weeks of treatment with Atopica for Cats, 78 per cent of cats were considered "comfortable" with satisfactory levels of grooming3 - a key indicator of a healthy cat. Additionally, Atopica for Cats is proven to significantly reduce unsightly and painful skin lesions and has a proven safety profile.
Anne-Laure Driscoll, Atopica Brand Manager, Novartis Animal Health UK, said: "Veterinarians and pet owners understand the discomfort and frustration of an itchy pet. We are pleased to add Atopica for Cats to our proven family of Atopica products, offering an effective treatment for cats suffering from the extreme discomfort associated with allergic dermatitis."
Developed specifically for domestic felines, Atopica for Cats is an oral solution which Novartis says is easy-to-dose and administer. In studies, approximately one-third of cats took the medicine in their food and two-thirds were dosed directly into the mouth3,4. According to the company, the product offers a unique mode of action that specifically targets immune cells such as the T-lymphocytes involved in the allergic reaction. In this way, Atopica for Cats blocks the production of inflammatory cytokines, molecules that fuel the allergic response, breaking the recurrent itch/scratch cycle.
Dr. Keith Hnilica, DVM, MS, MBA and DACVD, and author of Small Animal Dermatology: A Color Atlas and Therapeutic Guide (3rd ed), said: "Atopica for Cats has the potential to change how our profession treats the itchy cat. For the first time ever, we have a safe, highly effective, approved treatment for cats with allergic dermatitis. And because Atopica for Cats is not a corticosteroid, I can prescribe it for long-term use without worrying about the health risks that can be associated with steroids."
References
Jurox says Alfaxan Multidose is the bioequivalent to unpreserved Alfaxan, however the preserved formulation reduces the risk of microbial contamination, providing repeatable and reliable anaesthesia.
Alfaxan Multidose is available in two presentations of 10ml and 20ml, with the 20ml presentation priced at an equivalent price per ml as the current 10ml Alfaxan unpreserved presentation.
Jurox says there has been unprecedented interest in the new product, with the company taking pre-orders for the 20ml presentation from 60 different accounts at BSAVA this year.
Richard Beckwith, country manager at Jurox, said: "The introduction of Alfaxan Multidose to our anaesthesia and analgesia portfolio ensures that Alfaxan is more versatile than ever.
"The Alfaxan range continues to provide greater certainty and control during anaesthetic procedures, contributing towards better patient stability and a stress-free experience for the team."
For more information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
The practice makes ecobricks by packing all sorts of plastic waste tightly into plastic bottles which can then be joined together using tyres, silicone, cob or cement and used for a wide range of purposes in gardens, play parks and for making all types of structures with.
The ecobrick initiative was launched by the Global Ecobrick Alliance, which describes itself as an Earth Enterprise focused on solving plastic pollution through the dissemination of the low-tech, educational, open source ecobrick technology. It also operates a website which lists a wide range of organisations throughout the world where newly-made ecobricks can be delivered to.
White Cross Vets operates 19 practices, with four in the local area in Gateacre, West Derby, St Helens and Widnes, and is now exploring how it can roll out the scheme across the group. Other green initiatives White Cross Vets is pioneering include rolling out energy efficient LED lighting across its practices and heavily promoting the Cycle to Work scheme.
Helen Morris, from White Cross Vets, said: "In our industry almost everything comes packed in unrecyclable plastics, from small syringe packets through to large delivery bags and the plastic on the backs of patient labels, which we print hundreds of every day.
"As a result, we decided to look at how we might be able to put it to good use, rather than simply putting it in the bin and came across ecobricks. By taking the time to fill the bottles with plastic, we can significantly reduce the waste we send to landfill, and cut the amount of plastic that ends up littering the planet and ultimately finds its way into the sea. We are now making them every week and the whole team gets involved, which is rewarding for everyone involved."
Medivet owns 245 veterinary practices in the UK and its rate of practice acquisition had tripled in the last 12 months.
CEO, Arnold Levy said: "The 25 strong Regional Directors Team is a key strategic line of management and support for all our existing practices, and they are central to the successful integration of our new practices into our hub and spoke model. Even though each of our Regional Directors is an experienced, qualified veterinary surgeon, it is vital that they have time, knowledge and understanding of the Medivet business and operation to confidently support their practices in line with our model, in the right way.
"With the support of the Leadership Team, we will be using these next few months to ensure this newly formed group have all the skills needed to do just that."
Arnold added: "We have taken this deliberate decision to ensure we can maintain the very highest standards of client and patient care. Where our management team and support structures are already in place we will continue with our new acquisitions program, and once our Regional Management operation is fully embedded, we will confidently continue to grow our business in a sustainable, people and patient-first way."
Speaking at Improve International's OV Conference last week, Dr Wright cited increased pet travel and importation as key risk factors, including the growing number of rescued dogs arriving in the UK from countries in Europe and further afield.
Dr Wright highlighted the Rhipicephalus tick (Rhipicephalus sanguineus) as being a particular cause for concern, as it can transmit Ehrlichia canis, Anaplasma platys, Rickettsias, Babesia vogeli and Hepatozoon.
Dr Wright said that Ehrlichia canis and Anaplasma platys are among the most common tick-borne diseases in imported dogs, particularly those arriving from Eastern and Southern Europe. There were also three cases of Hepatozoon canis in 2018, caused by dogs ingesting Rhipicephalus ticks while grooming.
According to figures from a Bristol University Pet Travel survey, 54.5% of dog travel on the Pet Travel Scheme from the UK is to France with Southern European countries also popular destinations. These are all countries in which Rhipicephalus is present and on the increase. Dr Wright said that the ticks are moving north into Austria, Switzerland, Central France, Romania and Bulgaria.
During the last few months, he has also been alerted to ticks found on dogs coming in from North America, Latin America and Africa. These bring with them the risk of new diseases, including a variety of zoonotic rickettssial pathogens, such as Rickettsia Rickettsii, which causes Rocky Mountain Spotty Fever.
To address this issue Dr Wright urged vets to redouble their efforts on tick prevention. In particular, he recommended tick prevention pre/during and post travel, using products that offer rapid kill and repellency in order to reduce transmission, repellents being especially important in Leishmania infantum and Rhipicephalus-endemic countries.
Dr Wright recommended drilling clients and staff on tick removal and reminding them that finding a tick on a pet is not a failure as no product is 100% reliable and it is easy to miss them in long-haired dogs. He also suggested asking clients to take photos of any ticks they find on their pet while abroad so that their vet will know on their return what pathogens they may have been exposed to. If necessary, the Public Health England Tick Surveillance Scheme can help with identification.
Dr Wright suggested that legislation to enforce tick treatment on entry was a poor strategy used in isolation as pets would still be exposed while abroad and no product is completely reliable. It would be useful however, to raise awareness and show that we are taking the issue of tick-borne disease seriously.
He said: "We’re seeing a significant increase in pet travel and import a wider range of countries from which dogs are being imported and this is significantly increasing our exposure to exotic ticks.
"What’s news about this is that while you could argue that diseases such as Lyme Disease are ‘lifestyle’ diseases because people and dogs are exposed to our native ticks while out enjoying the countryside, the Rhipicephalus tick comes to your home, exposing you to a wealth of rickettsial diseases for the first time. We are already seeing instances of this in France, Germany and Scandinavia and, as pet travel continues to grow, the risk here will only increase. It’s equally possible that a dog with a native tick could travel aboard and return hosting a new pathogen.
"The only way to manage this risk is to provide consistent advice to the public and to support increased disease surveillance. Vigilance is key – assume that any travelling dog may have ticks and do not assume that because it is tick-treated, it’s a case of ‘job done.’"
He said: "Put the onus on clients - gently. Remind them to seek advice, to check for ticks and to keep tick treatments up to date. Also remind them to visit the practice with their dog as soon as possible on their return. If you do find exotic ticks, please send them to the Tick Surveillance Scheme for identification."
He added: "If you know an owner who is planning to adopt a dog from abroad, explain the risks to them and encourage them to adopt from the UK. If they are determined to go ahead, work with them to ensure that you reduce the risk of exotic ticks arriving with their new family members. The risk to human and animal health from an infestation should not be underestimated."
Direct Line made Freedom of Information requests to 44 police forces in the UK, of which 38 were able to provide usable data.
The number of dogs reported stolen in 2017 was 7% up on 2016, which in turn was 14% higher than in 2015.
In second place after Staffies (210 thefts) came crossbreeds (82 thefts), followed by French Bulldogs (61 thefts).
Geographically, the canine crime capital of the UK is, wait for it ... Yorkshire. Eeh by gum.
There were 346 reported dog thefts in Yorkshire and the Humberside, compared to 312 in the North West and 216 in the South East.
If you want to reduce your chances of being the victim of crime by owning the least stolen dog in the safest area, the data suggests you should buy a Springer and go and live in Wales.
Photo: English Staffordshire Bull Terrier, Nieuwland Photography / Shutterstock.
Alfaxan 10mg/mL solution for injection for dogs and cats is licensed as an induction agent prior to inhalation anaesthesia and as a sole anaesthetic agent for the induction and maintenance of anaesthesia for the performance of examination or surgical procedures. Jurox highlights that it has been safely used in patients from 12 weeks of age, for the induction of anaesthesia prior to delivery of puppies by caesarean section and for maintenance anaesthesia in procedures lasting up to an hour.
Jurox offers the following advice: "Part 1 (2) of Schedule 4 of the Veterinary Medicines Regulations states that 'if there is no authorised veterinary medicinal product' then the cascade may be followed. Alfaxan is an available and authorised veterinary medicinal product with very similar indications and therefore there is no clinical need to resort to non-licensed formulations of propofol, under cascade, for veterinary intravenous anaesthesia."
The company says that its UK team of veterinary surgeons will again respond proactively to the propofol shortage by delivering educational support to veterinary professionals and assisting them through the change to another veterinary licensed product for the anaesthesia of cats and dogs should they wish.
If you would like to discuss specific cases or need support using Alfaxan for the first time, contact Jurox on 0800 500 3171 or email alfaxan@jurox.co.uk